University Clinic of Pulmonary and Allergic Diseases Golnik

Primary Bedaquiline-Resistant Tuberculosis in an Afghan Migrant to Switzerland: Diagnostic and Treatment Challenges in a High-Resource Setting.

Bedaquiline, classified as a WHO 2019 group A drug, is a core component of BPaLM, revolutionizing the treatment of MDR/RR tuberculosis (TB). Since 2015, however, concerns about acquired and primary bedaquiline resistance have emerged. We report a diagnostically challenging case o...

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Purpose Of Review Oxygen therapy is a key component of interstitial lung disease (ILD) management. This review summarizes the current evidence and explores how to balance its benefits and burdens in people with ILD.Recent Findings Hypoxemia frequently occurs in ILD and is associa...